Literature DB >> 7053721

Cimetidine-associated exacerbation of cutaneous lupus erythematosus.

B L Davidson, J N Gilliam, P E Lipsky.   

Abstract

A patient with systemic lupus erythematosus (SLE) had new LE skin lesions develop following the initiation of cimetidine, a drug that is known to influence a variety of cellular functions. The temporal relationship between the onset of cutaneous LE with the ingestion of cimetidine is reported to alert others to the possibility that this H2 receptor antagonist may exacerbate cutaneous disease activity in patients with LE.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053721

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

Review 2.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 3.  Cimetidine as an immune response modifier.

Authors:  R Hast; P Bernell; M Hansson
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 4.  Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.

Authors:  Sangita Biswas; Stephen H Benedict; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2012-06-07       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.